Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Lysosomal Storage Diseases 1.4.3 Diabetes 1.4.4 Obesity 1.4.5 Inherited Metabolic Disorders 1.4.6 Hypercholesterolemia 1.5 Market by Application 1.5.1 Global Metabolic Disorder Therapeutics Market Share by Application (2014-2025) 1.5.2 Oral 1.5.3 Parenteral 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Metabolic Disorder Therapeutics Market Size 2.2 Metabolic Disorder Therapeutics Growth Trends by Regions 2.2.1 Metabolic Disorder Therapeutics Market Size by Regions (2014-2025) 2.2.2 Metabolic Disorder Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Metabolic Disorder Therapeutics Market Size by Manufacturers 3.1.1 Global Metabolic Disorder Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Metabolic Disorder Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Metabolic Disorder Therapeutics Key Players Head office and Area Served 3.3 Key Players Metabolic Disorder Therapeutics Product/Solution/Service 3.4 Date of Enter into Metabolic Disorder Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Metabolic Disorder Therapeutics Market Size by Type (2014-2019) 4.2 Global Metabolic Disorder Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Metabolic Disorder Therapeutics Market Size (2014-2019) 5.2 Metabolic Disorder Therapeutics Key Players in United States 5.3 United States Metabolic Disorder Therapeutics Market Size by Type 5.4 United States Metabolic Disorder Therapeutics Market Size by Application 6 Europe 6.1 Europe Metabolic Disorder Therapeutics Market Size (2014-2019) 6.2 Metabolic Disorder Therapeutics Key Players in Europe 6.3 Europe Metabolic Disorder Therapeutics Market Size by Type 6.4 Europe Metabolic Disorder Therapeutics Market Size by Application 7 China 7.1 China Metabolic Disorder Therapeutics Market Size (2014-2019) 7.2 Metabolic Disorder Therapeutics Key Players in China 7.3 China Metabolic Disorder Therapeutics Market Size by Type 7.4 China Metabolic Disorder Therapeutics Market Size by Application 8 Japan 8.1 Japan Metabolic Disorder Therapeutics Market Size (2014-2019) 8.2 Metabolic Disorder Therapeutics Key Players in Japan 8.3 Japan Metabolic Disorder Therapeutics Market Size by Type 8.4 Japan Metabolic Disorder Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Metabolic Disorder Therapeutics Market Size (2014-2019) 9.2 Metabolic Disorder Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Metabolic Disorder Therapeutics Market Size by Type 9.4 Southeast Asia Metabolic Disorder Therapeutics Market Size by Application 10 India 10.1 India Metabolic Disorder Therapeutics Market Size (2014-2019) 10.2 Metabolic Disorder Therapeutics Key Players in India 10.3 India Metabolic Disorder Therapeutics Market Size by Type 10.4 India Metabolic Disorder Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Metabolic Disorder Therapeutics Market Size (2014-2019) 11.2 Metabolic Disorder Therapeutics Key Players in Central & South America 11.3 Central & South America Metabolic Disorder Therapeutics Market Size by Type 11.4 Central & South America Metabolic Disorder Therapeutics Market Size by Application 12 International Players Profiles 12.1 Novo Nordisk A/S 12.1.1 Novo Nordisk A/S Company Details 12.1.2 Company Description and Business Overview 12.1.3 Metabolic Disorder Therapeutics Introduction 12.1.4 Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.1.5 Novo Nordisk A/S Recent Development 12.2 Sanofi S.A. 12.2.1 Sanofi S.A. Company Details 12.2.2 Company Description and Business Overview 12.2.3 Metabolic Disorder Therapeutics Introduction 12.2.4 Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.2.5 Sanofi S.A. Recent Development 12.3 Boehringer Ingelheim GmbH 12.3.1 Boehringer Ingelheim GmbH Company Details 12.3.2 Company Description and Business Overview 12.3.3 Metabolic Disorder Therapeutics Introduction 12.3.4 Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.3.5 Boehringer Ingelheim GmbH Recent Development 12.4 Eli Lilly and Company 12.4.1 Eli Lilly and Company Company Details 12.4.2 Company Description and Business Overview 12.4.3 Metabolic Disorder Therapeutics Introduction 12.4.4 Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.4.5 Eli Lilly and Company Recent Development 12.5 Merck KgaA 12.5.1 Merck KgaA Company Details 12.5.2 Company Description and Business Overview 12.5.3 Metabolic Disorder Therapeutics Introduction 12.5.4 Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.5.5 Merck KgaA Recent Development 12.6 Amgen, Inc. 12.6.1 Amgen, Inc. Company Details 12.6.2 Company Description and Business Overview 12.6.3 Metabolic Disorder Therapeutics Introduction 12.6.4 Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.6.5 Amgen, Inc. Recent Development 12.7 AstraZeneca PLC 12.7.1 AstraZeneca PLC Company Details 12.7.2 Company Description and Business Overview 12.7.3 Metabolic Disorder Therapeutics Introduction 12.7.4 AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.7.5 AstraZeneca PLC Recent Development 12.8 Actelion Pharmaceuticals Ltd. 12.8.1 Actelion Pharmaceuticals Ltd. Company Details 12.8.2 Company Description and Business Overview 12.8.3 Metabolic Disorder Therapeutics Introduction 12.8.4 Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.8.5 Actelion Pharmaceuticals Ltd. Recent Development 12.9 Shire PLC 12.9.1 Shire PLC Company Details 12.9.2 Company Description and Business Overview 12.9.3 Metabolic Disorder Therapeutics Introduction 12.9.4 Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.9.5 Shire PLC Recent Development 12.10 AbbVie, Inc. 12.10.1 AbbVie, Inc. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Metabolic Disorder Therapeutics Introduction 12.10.4 AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019) 12.10.5 AbbVie, Inc. Recent Development 12.11 Biocon Ltd. 12.12 BioMarin Pharmaceutical, Inc. 12.13 Bristol-Myers Squibb Company 12.14 Cipla, Inc. 12.15 CymaBay Therapeutics, Inc. 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Metabolic Disorder Therapeutics Key Market Segments Table Key Players Metabolic Disorder Therapeutics Covered Table Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Type 2014-2025 Figure Lysosomal Storage Diseases Figures Table Key Players of Lysosomal Storage Diseases Figure Diabetes Figures Table Key Players of Diabetes Figure Obesity Figures Table Key Players of Obesity Figure Inherited Metabolic Disorders Figures Table Key Players of Inherited Metabolic Disorders Figure Hypercholesterolemia Figures Table Key Players of Hypercholesterolemia Table Global Metabolic Disorder Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Oral Case Studies Figure Parenteral Case Studies Figure Others Case Studies Figure Metabolic Disorder Therapeutics Report Years Considered Table Global Metabolic Disorder Therapeutics Market Size 2014-2025 (Million US$) Figure Global Metabolic Disorder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Metabolic Disorder Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Metabolic Disorder Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Metabolic Disorder Therapeutics Market Share by Regions 2014-2019 Figure Global Metabolic Disorder Therapeutics Market Share by Regions 2014-2019 Figure Global Metabolic Disorder Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Metabolic Disorder Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Metabolic Disorder Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Metabolic Disorder Therapeutics Market Share by Manufacturers in 2018 Table Global Metabolic Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Metabolic Disorder Therapeutics Product/Solution/Service Table Date of Enter into Metabolic Disorder Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Metabolic Disorder Therapeutics Market Size Share by Type (2014-2019) Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Type (2014-2019) Table Global Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Metabolic Disorder Therapeutics Market Size Share by Application (2014-2019) Figure Global Metabolic Disorder Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Metabolic Disorder Therapeutics Revenue Market Share by Application in 2018 Figure United States Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table United States Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table United States Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure Europe Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table Europe Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table Europe Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure China Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table China Metabolic Disorder Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table China Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure Japan Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table Japan Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table Japan Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table Southeast Asia Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure India Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table India Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table India Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Figure Central & South America Metabolic Disorder Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Metabolic Disorder Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Metabolic Disorder Therapeutics Market Share (2018-2019) Table Central & South America Metabolic Disorder Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Metabolic Disorder Therapeutics Market Share by Type (2014-2019) Table Central & South America Metabolic Disorder Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Metabolic Disorder Therapeutics Market Share by Application (2014-2019) Table Novo Nordisk A/S Company Details Table Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2014-2019) (Million US$) Figure Novo Nordisk A/S Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Novo Nordisk A/S Recent Development Table Sanofi S.A. Company Details Table Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Sanofi S.A. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Sanofi S.A. Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Boehringer Ingelheim GmbH Recent Development Table Eli Lilly and Company Company Details Table Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Eli Lilly and Company Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Eli Lilly and Company Recent Development Table Merck KgaA Company Details Table Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Merck KgaA Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Merck KgaA Recent Development Table Amgen, Inc. Company Details Table Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Amgen, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Amgen, Inc. Recent Development Table AstraZeneca PLC Company Details Table AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure AstraZeneca PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table AstraZeneca PLC Recent Development Table Actelion Pharmaceuticals Ltd. Company Details Table Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Actelion Pharmaceuticals Ltd. Recent Development Table Shire PLC Company Details Table Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure Shire PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table Shire PLC Recent Development Table AbbVie, Inc. Company Details Table AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)(Million US$) Figure AbbVie, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2014-2019) Table AbbVie, Inc. Recent Development Table Biocon Ltd. Company Details Table BioMarin Pharmaceutical, Inc. Company Details Table Bristol-Myers Squibb Company Company Details Table Cipla, Inc. Company Details Table CymaBay Therapeutics, Inc. Company Details Table Global Metabolic Disorder Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Metabolic Disorder Therapeutics Market Size Share by Regions (2019-2025) Figure Global Metabolic Disorder Therapeutics Market Size Share by Regions in 2025 Figure United States Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Metabolic Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Metabolic Disorder Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Metabolic Disorder Therapeutics Market Size by Product (2019-2025) Figure Global Metabolic Disorder Therapeutics Market Size by Product in 2025 Table Global Metabolic Disorder Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Metabolic Disorder Therapeutics Market Size by Application (2019-2025) Figure Global Metabolic Disorder Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novo Nordisk A/S Sanofi S.A. Boehringer Ingelheim GmbH Eli Lilly and Company Merck KgaA Amgen, Inc. AstraZeneca PLC Actelion Pharmaceuticals Ltd. Shire PLC AbbVie, Inc. Biocon Ltd. BioMarin Pharmaceutical, Inc. Bristol-Myers Squibb Company Cipla, Inc. CymaBay Therapeutics, Inc.